Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
JCI Insight|August 18, 2017
VIPAR, a quantitative approach to 3D histopathology applied to lymphatic malformationsRené Hägerling, Dominik Drees, Aaron Scherzinger, et al.
Journal of Translational Medicine|November 28, 2019
A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinomaApostolos Sarivalasis, Caroline Boudousquié, Klara Balint, et al.
Iscience|March 5, 2021
Activation of amino acid metabolic program in cardiac HIF1-alpha-deficient miceIvan Menendez-Montes, Beatriz Escobar, Manuel J Gomez, et al.
Frontiers in Immunology|August 24, 2019
A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma-A Proof of Antigen Discovery Feasibility in Three PatientsMichal Bassani-Sternberg, Antonia Digklia, Florian Huber, et al.
Nature Communications|September 4, 2015
Novel mutations in PIEZO1 cause an autosomal recessive generalized lymphatic dysplasia with non-immune hydrops fetalisElisavet Fotiou, Silvia Martin-Almedina, Michael A Simpson, et al.
Nature Communications|April 28, 2019
Author Correction: Novel mutations in PIEZO1 cause an autosomal recessive generalized lymphatic dysplasia with non-immune hydrops fetalisElisavet Fotiou, Silvia Martin-Almedina, Michael A Simpson, et al.
Cell Stem Cell|March 29, 2008
The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled by a Wnt/beta-catenin pathwayYibing Qyang, Silvia Martin-Puig, Murali Chiravuri, et al.
Leukemia|March 18, 2021
The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphomaJuan Garcia Valero, Alba Matas-Céspedes, Fabián Arenas, et al.
Human Molecular Genetics|April 27, 2024
Pathogenic variants in HGF give rise to childhood-to-late onset primary lymphoedema by loss of functionMurat Alpaslan, Elodie Fastré, Sandrine Mestre, et al.
Future Oncology (London, England)|August 12, 2024
Clinical protocol phase II study of tumor infiltrating lymphocytes in advanced tumors with alterations in the SWI/SNF complex: the TILTS studyJuan Martin-Liberal, Elena Garralda, Jesús García-Donas, et al.
Pageof 7